If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

Share Price is delayed by 15 minutes
Get Live Data
124.00    0.40 (0.32%)
Bid:
123.20
Ask:
124.00
Spread: 0.80 (0.649%)
Market Cap: £516.35m
JHD Live PriceLast checked at - London Stock Exchange

Intraday James Halstead Share Chart

Interim Results

31 Mar 2016 07:00

RNS Number : 6178T
James Halstead PLC
31 March 2016
Β 

Β 

31 March 2016

JAMES HALSTEAD PLC

Β 

INTERIM RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2015

Β 

Key Figures

Β 

James Halstead plc, the AIM listed manufacturer and international distributor of commercial floor coverings, reports:

Β 

Β· Revenue lower at Β£114.7 million - a decrease of 2.1% (on a constant exchange rate basis increased by 2.9%)

Β· Operating profit higher at Β£23.3 million - an increase of 7.7%

Β· Pre-tax profit higher at Β£23.0 million - an increase of 7.5%

Β· Basic earnings per ordinary share 8.6p - an increase of 10.3%

Β· Interim dividend increased to a record 3.5p - an increase of 11.4%

Β· Net cash at Β£55.9 million

Β 

The Chief Executive, Mr. Mark Halstead, commented:

Β 

"We continue to build on the robust performance of the last 15 years and despite having the strength of sterling as a strong headwind to our exports in the first half we have again reported a record profit".

Β 

Β 

Enquiries:

Β 

James Halstead

0161 767 2500

Mark Halstead, Chief Executive

Β 

Gordon Oliver, Finance Director

Β 

Β 

Β 

Hudson Sandler

020 7796 4133

Nick Lyon

Β 

Β 

Β 

Panmure Gordon (Nomad and Joint Broker)

020 7886 2500

Ben Thorne

Andrew Potts

Β 

Β 

Β 

Β 

Arden Partners (Joint Broker)

Chris Hardie

Β 

020 7614 5900

Β 

Β 

CHAIRMAN'S STATEMENT

Given the strength of our currency here in the UK and the consequential effects on the translation of our results it is gratifying to report improved pre-tax profit of Β£23.0 million (2014: Β£21.4 million), an increase of 7.5%.

Β 

I can report that revenue of Β£114.7 million (2014: Β£117.2 million) was 2.1% below the comparative, owing to the strength of sterling over the first six months. This adverse situation has mathematically lowered the currency equivalent. At constant exchange rates sales were 2.9% ahead.

Β 

Β 

Trading

Β 

As already noted, the translation of overseas sales was affected by adverse exchange rates but there was growth in most markets when measured in local currency. Polyflor Canada Inc. continues to expand with a 32% growth in turnover. It is pleasing to report that our flooring is refurbishing store chains such as Loblaws and Indigo Kids in many cities. James Halstead France reported a near 10% increase and notable projects include the Alstrom Epsilon building complex in the heart of Lyon.

Β 

In our more established markets, Objectflor, our central European operation based in Cologne reported 4% growth in sales. Our latest range, "Expona Flow" has already been fitted in sales areas within Ikea stores in Kaiserlautern, Berlin and Ravensburg and long term customers such as the fashion retail chain Modepark RΓΆther continue to expand. It is pleasing to report that "Simplay", our loose lay vinyl tile, was awarded a "Pro K Award" for innovative product development in the area of consumer plastics.

Β 

In looking at our home territory, it is clear that Polyflor UK maintains its strong presence, with notable projects such as Croydon University Hospital, the Vision Express retail chain and the new Pontypridd Lido at Ynysangharad Park. The UK market, representing about 39% of total turnover, has shown a solid performance with growth of 4.5% in the period, which is ahead of the market growth over that period.

Β 

Australia and New Zealand have reported 8-9% growth with the former providing flooring to Aldi stores across the country and the latter to Burwood Hospital in Christchurch (the country's largest ever healthcare project) and are just two examples of the growth in this region.

Β 

Gross margins have improved by 1.5% despite the adverse effects of foreign exchange rates on overseas trading. The reasons for this are threefold: being the effects of increased output of heterogeneous flooring, reduced raw material prices (in part helped by the strength of sterling) and energy savings. Overheads are 3.2% below the comparative period but on a par when viewed on a constant exchange rate basis.

Β 

The balance sheet is, as usual, robust with the component showing the largest change being cash which stands at Β£55.9 million some 19.5% ahead of the comparative of last year (2014: Β£46.7 million) and after dividends paid out of Β£22.8 million.

Β 

Earnings per Share

Β 

Our basic earnings per share at 8.6p are 10.3% ahead of the comparative of 7.8p and the Board is pleased to propose an increased interim dividend.

Β 

Having regard to cash, I am pleased to say that a dividend of 3.5p will be paid (2015: 3.142p), representing an 11.4% increase and this reflects both the strength of earnings and the cash reserves of the Company. This will be payable on 3 June 2016 to those shareholders on the register at the close of business on 6 May 2016.Β 

Β 

Outlook

Β 

We have delivered a solid first half performance.

Β 

Early trading in the second half has been challenging, with the UK noticeably facing rougher trading conditions. Nevertheless, our global footprint continues to provide good opportunities for advancement and I am confident that the depth of our experience of this industry, which has stood us in good stead for a generation, will continue to lead us to greater success.

Β 

Many are quick to apply hindsight to business but I think that the accumulation of knowledge our team offers James Halstead something better- insight.

Β 

Our group remains focused on sales growth and has every expectation of continued progress in the second half year.

Β 

Β 

Geoffrey Halstead

Chairman

31 March 2016

Β 

Β 

Β 

Consolidated Income Statement

for the half-year ended 31 December 2015

Β 

Β 

Β 

Half-yearΒ 

endedΒ 

31.12.15Β 

Β£'000Β 

Β 

Half-yearΒ 

endedΒ 

31.12.14Β 

Β£'000Β 

Β 

YearΒ 

endedΒ 

30.06.15Β 

Β£'000Β 

Β 

Β 

Β 

Β 

Revenue

114,675Β 

117,168Β 

227,261Β 

Β 

Β 

Β 

Β 

Operating profit

23,311Β 

21,640Β 

44,720Β 

Net finance cost

(272)

(215)

(536)

Β 

Β 

Β 

Β 

Profit before income tax

23,039Β 

21,425Β 

44,184Β 

Β 

Β 

Β 

Β 

Income tax expense

(5,304)

(5,222)

(10,250)

Β 

Β 

Β 

Β 

Profit for the period

17,735Β 

16,203Β 

33,934Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Earnings per ordinary share of 5p:

Β 

Β 

Β 

-basic

8.6p

7.8p

16.4p

-diluted

8.5p

7.8p

16.3p

Β 

Β 

Β 

Β 

All amounts relate to continuing operations.

Β 

Details of dividends paid and proposed are given in note 4.

Β 

Β 

Β 

Β 

Consolidated Balance Sheet

as at 31 December 2015

Β 

Β 

Half-year

ended

31.12.15

Β£'000

Half-year

ended

31.12.14

Β£'000

Year

ended

30.06.15

Β£'000

Non-current assets

Β 

Β 

Β 

Property, plant and equipment

32,185

31,954

31,172

Intangible assets

3,232

3,232

3,232

Deferred tax assets

5,061

5,641

4,908

Β 

40,478

40,827

39,312

Current assets

Β 

Β 

Β 

Inventories

58,567

58,025

58,707

Trade and other receivables

27,909

29,438

31,402

Derivative financial instruments

696

2,427

2,242

Cash and cash equivalents

55,850

46,716

47,428

Β 

143,022

136,606

139,779

Current liabilities

Β 

Β 

Β 

Trade and other payables

50,634

54,235

48,022

Derivative financial instruments

635

286

8

Current income tax liabilities

5,346

4,902

4,814

Dividend payable

16,303

-

-

Β 

72,918

59,423

52,844

Β 

Β 

Β 

Β 

Net current assets

70,104

77,183

86,935

Β 

Β 

Β 

Β 

Non-current liabilities

Β 

Β 

Β 

Retirement benefit obligations

18,904

20,115

18,492

Deferred tax liabilities

709

744

709

Borrowings

200

200

200

Other payables

390

389

386

Β 

20,203

21,448

19,787

Β 

Β 

Β 

Β 

Net assets

90,379

96,562

106,460

Β 

Β 

Β 

Β 

Equity

Β 

Β 

Β 

Equity share capital

10,373

10,363

10,364

Equity share capital (B shares)

160

160

160

Β 

10,533

10,523

10,524

Share premium account

3,096

2,899

2,917

Capital redemption reserve

1,174

1,174

1,174

Currency translation reserve

87

1,455

(782)

Hedging reserve

14

1,237

1,427

Retained earnings

75,475

79,274

91,200

Β 

Β 

Β 

Β 

Total equity attributable to shareholders of the parent

90,379

96,562

106,460

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Consolidated Cash Flow Statement

for the half-year ended 31 December 2015

Β 

Β 

Half-yearΒ 

endedΒ 

31.12.15Β 

Β£'000Β 

Half-yearΒ 

endedΒ 

31.12.14Β 

Β£'000Β 

YearΒ 

endedΒ 

30.06.15Β 

Β£'000Β 

Β 

Β 

Β 

Β 

Cash inflow from operations

31,059Β 

28,315Β 

42,015Β 

Net interest received

96Β 

138Β 

150Β 

Taxation paid

(4,729)

(3,671)

(8,416)

Β 

Β 

Β 

Β 

Cash inflow from operating activities

26,426Β 

24,782Β 

33,749Β 

Β 

Β 

Β 

Β 

Purchase of property, plant and equipment

(2,180)

(2,297)

(3,855)

Proceeds from disposal of property, plant and equipment

166Β 

91Β 

187Β 

Cash outflow from investing activities

(2,014)Β 

(2,206)Β 

(3.668)

Β 

Β 

Β 

Β 

Equity dividends paid

(16,302)

(14,507)

(21,020)

Shares issued

188Β 

169Β 

188Β 

Cash outflow from financing activities

(16,114)

(14,338)

(20,832)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net increase in cash and cash equivalents

8,298Β 

8,238Β 

9,249

Effect of exchange differences

124

Β (199)

(498)

Cash and cash equivalents at start of period

47,428Β 

38,677Β 

38,677Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at end of period

55,850Β 

46,716Β 

47,428Β 

Β 

Β 

Β 

Consolidated Statement of Comprehensive Income

for the half-year ended 31 December 2015

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Half-yearΒ 

endedΒ 

31.12.15Β 

Β£'000Β 

Β 

Half-yearΒ 

endedΒ 

31.12.14Β 

Β£'000Β 

Β 

YearΒ 

endedΒ 

30.06.15Β 

Β£'000Β 

Β 

Profit for the period

17,735Β 

16,203Β 

33,934Β 

Β 

Other comprehensive income net of tax:

Β 

Β 

Β 

Actuarial loss on the defined benefit scheme

Β (855)

(3,392)

(2,720)

Deferred taxation - change of rate

-Β 

-Β 

35Β 

Foreign currency translation differences

869

(1,631)

(3,868)

Fair value movements on hedging instruments

(1,413)

1,133

1,323Β 

Β 

Β 

Β 

Β 

Other comprehensive income for the period net of tax

Β (1,399)

Β  (3,890)

(5,230)

Β 

Β 

Β 

Β 

Total comprehensive income for the period

16,336Β 

12,313Β 

28,704Β 

Β 

Β 

Β 

Β 

Attributable to equity holders of the

Β 

Β 

Β 

parent company

16,336Β 

12,313Β 

28,704Β 

Β 

Β 

Β 

Β 

Β 

Notes to the Interim Results

for the half-year ended 31 December 2015

Β 

1.

Basis of preparation

Β 

Β 

The interim financial statements are unaudited and do not constitute statutory accounts as defined within the Companies Act 2006.

Β 

The principal accounting policies applied in the preparation of the consolidated interim statements are those set out in the annual report and accounts for the year ended 30 June 2015.

Β 

The figures for the year ended 30 June 2015 are an abridged statement of the group audited accounts for that year. The financial statements for the year ended 30 June 2015 were audited and have been delivered to the Registrar of Companies.

Β 

As is permitted by the AIM rules, the directors have not adopted the requirements of IAS34 'Interim Financial Reporting' in preparing the interim financial statements. Accordingly the interim financial statements are not in full compliance with IFRS.

Β 

Β 

2.

Taxation

Β 

Β 

Income tax has been provided at the rate of 23.0% (2014: 24.4%).

Β 

Β 

3.

Earnings per share

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Half-year

ended

31.12.15

Β£'000

Β 

Half-year

ended

31.12.14

Β£'000

Β 

Year

ended

30.06.15

Β£'000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

17,735

16,203

33,934

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Weighted average number of shares in issue

207,392,532

207,200,361

207,238,042

Β 

Β 

Dilution effect of outstanding share options

541,827

530,901

562,584

Β 

Β 

Diluted weighted average number shares

207,934,359

207,731,262

207,800,626

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Basic earnings per 5p ordinary share

8.6p

7.8p

16.4p

Β 

Β 

Diluted earnings per 5p ordinary share

8.5p

7.8p

16.3p

Β 

4.

Dividends

Β 

Β 

Β 

Β 

Β 

Half-year

ended

31.12.15

Β£'000

Half-year

ended

31.12.14

Β£'000

Year

ended

30.06.15

Β£'000

Β 

Equity dividends paid:

Β 

Β 

Β 

Β 

Β 

Final dividend for the year ended 30 June 2014

-

14,507

14,507

Β 

Interim dividend for the year ended 30 June 2015

-

-

6,513

Β 

Final dividend for the year ended 30 June 2015

16,302

-

-

Β 

Β 

16,302

14,507

21,020

Β 

Β 

Β 

Β 

Β 

Β 

Equity dividends proposed at the end of the period

Β 

Β 

Β 

Β 

Interim dividend

7,261

6,513

-

Β 

Final dividend

-

-

16,302

Β 

Β 

Equity dividends per share, paid and proposed are as follows

Β 

Β 

7.0p final dividend for the year ended 30 June 2014, paid on 5 December 2014

Β 

3.142p interim dividend for the year ended 30 June 2015, paid on 5 June 2015

7.858p final dividend for the year ended 30 June 2015, paid on 4 December 2015

3.5p interim dividend for the year ended 30 June 2016, payable on 3 June 2016, to those shareholders on the register at the close of business on 6 May 2016

In addition a 7.858p special dividend amounting to Β£16,303,000 was declared on 27 November 2015 and paid on 26 February 2016Β 

Β 

Β 

Β 

5.

Β 

Β 

Copies of the interim results

Β 

Β 

Copies of the interim results have been sent to shareholders who requested them. Further copies can be obtained from the Company's registered office, Beechfield, Hollinhurst Road, Radcliffe, Manchester, M26 1JN.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IR SDAFWSFMSEFD
Date   Source Headline
2nd Jul 20129:00 amRNSBlocklisting Interim Review
6th Jun 20124:40 pmRNSSecond Price Monitoring Extn
6th Jun 20124:35 pmRNSPrice Monitoring Extension
1st Jun 20127:00 amRNSTotal Voting Rights
25th May 20122:00 pmRNSDirector/PDMR Shareholding
1st May 20127:00 amRNSTotal Voting Rights
2nd Apr 20123:45 pmRNSDirector/PDMR Shareholding
29th Mar 20127:00 amRNSInterim Results
12th Mar 20124:35 pmRNSPrice Monitoring Extension
1st Mar 20127:00 amRNSTotal Voting Rights
30th Jan 20127:00 amRNSPre-Close Trading Statement
11th Jan 20127:00 amRNSAppointment of Broker
4th Jan 20127:00 amRNSAppointment of non-executive director
3rd Jan 20127:00 amRNSBlocklisting Interim Review
3rd Jan 20127:00 amRNSTotal Voting Rights
6th Dec 20111:00 pmRNSDirector's shareholding
5th Dec 20114:45 pmRNSChange in shareholdings
2nd Dec 20117:00 amRNSAGM Statement
30th Nov 201110:50 amRNSResult of Tender Offer
14th Nov 20117:00 amRNSTender Offer and Trading Update
1st Nov 20117:00 amRNSTotal Voting Rights
28th Oct 20112:00 pmRNSAnnual Financial Report
11th Oct 201111:00 amRNSChange in Director's Holding
3rd Oct 20117:00 amRNSPreliminary Results
6th Sep 20117:00 amRNSNotice of Results
15th Aug 20117:00 amRNSTotal Voting Rights
26th Jul 20117:00 amRNSPre-close Trading Statement
6th Jul 20118:45 amRNSDirector/PDMR Shareholding
1st Jul 20117:00 amRNSBlocklisting Interim Review
3rd May 20117:00 amRNSTotal Voting Rights
15th Apr 20112:40 pmRNSDirector/PDMR Shareholding
1st Apr 20117:00 amRNSTotal Voting Rights
31st Mar 20117:00 amRNSInterim Results
31st Jan 20112:00 pmRNSHolding(s) in Company
31st Jan 20117:00 amRNSPre-close Trading Statement
13th Jan 20113:30 pmRNSIssue of Equity and Total Voting Rights
12th Jan 20119:30 amRNSBonus Issue
4th Jan 20119:45 amRNSTotal Voting Rights
4th Jan 20119:10 amRNSBlocklisting Interim Review
21st Dec 20103:45 pmRNSDirector/PDMR Shareholding
3rd Dec 20107:00 amRNSAnnual General Meeting
1st Nov 20107:00 amRNSTotal Voting Rights
25th Oct 20109:15 amRNSAnnual Report and Accounts
25th Oct 20109:15 amRNSAnnual Report and Accounts
30th Sep 20107:00 amRNSPreliminary Results
23rd Jul 20107:00 amRNSPre-Close Trading Update
1st Jul 20107:00 amRNSBlocklisting Interim Review
6th Apr 201012:00 pmRNSTotal Voting Rights
31st Mar 20104:17 pmRNSDirector/PDMR Shareholding
31st Mar 20107:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.